Technical Analysis for SNY - Sanofi

Grade Last Price % Change Price Change
grade D 50.33 -2.02% -1.04
SNY closed down 2.02 percent on Friday, August 14, 2020, on approximately normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down
Historical SNY trend table...

Date Alert Name Type % Chg
Gapped Down Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Fell Below 50 DMA Bearish -2.02%
Narrow Range Bar Range Contraction -2.02%
NR7 Range Contraction -2.02%
Gapped Down Weakness -2.02%
Oversold Stochastic Weakness -2.02%
Crossed Above 50 DMA Bullish -2.82%
Stochastic Buy Signal Bullish -2.82%

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Sanofi researches, develops, manufactures, and markets healthcare products worldwide. The company operates through Pharmaceuticals, Human Vaccines, and Animal Health segments. Its principal products include Lantus and Apidra analogs of human insulin; Insuman, a range of human insulin solutions and suspensions; Amaryl, an oral once-daily sulfonylurea; BGStar and iBGStar blood glucose meters; enzyme replacement therapies, such as Cerezyme for Gaucher disease, Fabrazyme for Fabry, and Myozyme/Lumizyme for Pompe disease; Aubagio, an oral immunomodulator for multiple sclerosis; Taxotere, a taxane derivative for various cancer types; Eloxatine for colorectal cancer; and Jevtana for prostate cancer. The company's products also consist of thrombosis medicines, such as Plavix anti-platelet agent for atherothrombotic conditions and Lovenox to prevent and treat deep vein thrombosis; and cardiovascular medicines include Multaq anti-arrhythmic agent and Aprovel/CoAprovel for hypertension treatments. It also offers Renagel/Renvela oral phosphate binders used in patients with chronic kidney disease on dialysis to treat high phosphorus levels; Synvisc and Synvisc-One viscosupplements to treat pain associated with osteoarthritis of certain joints; and pediatric and influenza, adult and adolescent booster, meningitis and pneumonia, and travel and endemics vaccines. In addition, the company provides pharmaceuticals and vaccines used by veterinarians, farmers, and pet owners; consumer health care products to treat fever, pain, and digestive health areas; and generic medicines. Sanofi distributes its products through its sales force, as well as through physicians, pharmacies, hospitals, distributors, veterinaries, chemists, and wholesalers. It has alliance arrangements with Bristol-Myers Squibb, Regeneron, and Warner Chilcott. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1970 and is headquartered in Paris, France.
Cancer Healthcare Life Sciences Pharmaceutical Industry Pain Pharmaceuticals Prostate Cancer Health Sciences Multiple Sclerosis Dialysis Influenza Osteoarthritis Chronic Kidney Disease Hypertension Healthcare Products Cac 40 Colorectal Cancer Insulin Hepatotoxins Sanofi Bristol Myers Squibb Deep Vein Thrombosis Fever Pneumonia Thrombosis Consumer Health Care Products Gaucher Disease Pompe Disease Enzyme Replacement Therapies Regeneron

Is SNY a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 55.0
52 Week Low 37.62
Average Volume 1,202,896
200-Day Moving Average 48.66
50-Day Moving Average 51.66
20-Day Moving Average 52.01
10-Day Moving Average 51.48
Average True Range 1.00
ADX 11.8
+DI 21.29
-DI 30.18
Chandelier Exit (Long, 3 ATRs ) 51.99
Chandelier Exit (Short, 3 ATRs ) 53.06
Upper Bollinger Band 53.82
Lower Bollinger Band 50.21
Percent B (%b) 0.03
BandWidth 6.94
MACD Line -0.19
MACD Signal Line 0.03
MACD Histogram -0.2207
Fundamentals Value
Market Cap 126.4 Billion
Num Shares 2.51 Billion
EPS 4.31
Price-to-Earnings (P/E) Ratio 11.68
Price-to-Sales 2.74
Price-to-Book 1.72
PEG Ratio 1.86
Dividend 1.64
Dividend Yield 3.26%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 51.38
Resistance 3 (R3) 51.40 51.08 51.21
Resistance 2 (R2) 51.08 50.81 51.07 51.15
Resistance 1 (R1) 50.70 50.64 50.54 50.68 51.09
Pivot Point 50.38 50.38 50.30 50.37 50.38
Support 1 (S1) 50.00 50.11 49.84 49.98 49.57
Support 2 (S2) 49.68 49.94 49.67 49.51
Support 3 (S3) 49.30 49.68 49.46
Support 4 (S4) 49.28